Replies to post #2215 on SmurfVA's Random Picks

[SmurfVA]

SYN - I will scoop some shares tomorrow. Like to see SYN & CRIS make a run towards end of March here to end strong.

[Ned Serious]

SYN: $3.38 - Price target raised to $6 - I plan on holding through today and waiting for the Pertussis data to come in (hopefully positive) soon. Will probably sell on that spike (if it happens).

link : http://finance.yahoo.com/news/short-story-briefing-com-125001333.html

8:58 am Synthetic Biologics target raised to $6 at Maxim Group following meetings with mgmt

Maxim Group raises its SYN tgt to $6 from $3. Firm concludes that there are now multiple events ahead, including top-line data for Trimesta (oral estriol) in relapsing/remitting multiple sclerosis in April. In addition, SYN-004 (a second-generation product) should progress to the clinic (for the start of a phase 1b/2 trial) for the prevention of C-difficile infection. SYN-005 (mAb) for pertussis (whooping cough) is another catalyst that has shown compelling animal data (whooping cough is an unmet medical need), as well as the development of SYN-010 for C-IBS and related GI disorders and SYN-001 for life-threatening Acinetobacter (gram negative bacterium) infections.